Drug profile · INN
mefloquine hydrochloride
MEFLOQUINE HYDROCHLORIDE
mefloquine hydrochloride (MEFLOQUINE HYDROCHLORIDE) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — mefloquine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mefloquine hydrochloride (MEFLOQUINE HYDROCHLORIDE) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Ferriprotoporphyrin IX inhibitor
Primary target: Ferriprotoporphyrin IX
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mefloquine hydrochloride?
mefloquine hydrochloride (MEFLOQUINE HYDROCHLORIDE) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mefloquine hydrochloride?
MEFLOQUINE HYDROCHLORIDE is a marketed brand name for mefloquine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mefloquine hydrochloride?
mefloquine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.